| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.02▲ | 1.03▼ | 1.03▼ | 2.88▼ | 4.68▼ |
| MA10 | 1.02▲ | 1.02▲ | 1.03▼ | 4.15▼ | 5.01▼ |
| MA20 | 1.03▼ | 1.04▼ | 1.06▼ | 4.71▼ | 4.82▼ |
| MA50 | 1.02▲ | 2.17▼ | 3.63▼ | 5.11▼ | 3.96▼ |
| MA100 | 1.03▼ | 3.77▼ | 4.56▼ | 4.74▼ | N/A |
| MA200 | 1.06▼ | 4.61▼ | 4.83▼ | 4.11▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.093▲ | 0.139▲ | -0.510▼ | -0.294▼ |
| RSI | 47.464▼ | 23.010▼ | 19.912▼ | 22.255▼ | 31.000▼ |
| STOCH | 16.667▼ | 61.610 | 33.688 | 17.274▼ | 29.318 |
| WILL %R | -80.000▼ | -48.356 | -76.097▼ | -98.988▼ | -99.114▼ |
| CCI | -33.071 | 14.491 | -59.112 | -158.431▼ | -461.906▼ |
|
Tuesday, September 16, 2025 12:15 PM
The short position comes after Shkreli’s successful bet against aTyr Pharma (NASDAQ:ATYR), which saw that stock plummet 80% following failed clinical trial results. Shkreli had previously indicated he ...
|
|
Tuesday, September 16, 2025 07:17 AM
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
|
|
Monday, September 15, 2025 07:01 PM
Investing in aTyr Pharma presents a classic risk-reward scenario. The potential for significant returns is tempered by the high stakes involved in the upcoming phase 3 study results. Investors must ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/09/25 | 1.07 | 1.08 | 0.969 | 1.025 | 31,804,900 |
| 16/09/25 | 1.08 | 1.20 | 1.06 | 1.08 | 45,797,904 |
| 15/09/25 | 1.255 | 1.37 | 1.00 | 1.015 | 152,601,536 |
| 12/09/25 | 5.27 | 6.50 | 5.22 | 6.03 | 16,683,100 |
| 11/09/25 | 5.20 | 5.585 | 5.185 | 5.26 | 4,746,600 |
| 10/09/25 | 5.315 | 5.435 | 5.08 | 5.24 | 4,056,000 |
| 09/09/25 | 5.45 | 5.60 | 5.17 | 5.31 | 4,929,100 |
| 08/09/25 | 5.60 | 5.77 | 5.32 | 5.46 | 4,286,000 |
| 05/09/25 | 5.54 | 5.63 | 5.27 | 5.61 | 3,929,000 |
| 04/09/25 | 5.63 | 5.82 | 5.23 | 5.47 | 4,933,200 |
|
|
||||
|
|
||||
|
|